HIV protection in two shots a year gains approval in U.S. | CBC News

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

CBC

36 years ago #Chinese #military ended the #uprising of tens of thousands people fighting for more rights

After having to retrieve the first time the #PLA went to the #Tiananmensquare to destroy the main place of #protest

Though depicted as a #studentprotest in the west, it wasn't only #students , it was #workers and many others, too

#Repression hit them brutally afterwards

More at https://katika-kuehnreich.com/en/2025/06/04/36th-anniversary-of-the-tiananmen-massacre/

#China #Tiananmenmassacre #64 #jb0604 #天安门 #六四屠殺 #六四鎮壓 #VIIV #8964 #tankman

South Africa ‘can’t afford’ to pay for new anti-HIV drug, despite cut-price offer | Global development | The Guardian
https://www.theguardian.com/global-development/2023/nov/17/south-africa-hiv-cab-la-cabotegravir-viiv-healthcare

#SouthAfrica
#HIV
#AntiHIVDrug
#Cabotegravir
#CABLA
#Pepfar
#ViiV
#Cipla

South Africa ‘can’t afford’ to pay for new anti-HIV drug, despite cut-price offer

The jab, given every two months, has been offered on a non-profit basis, but it can’t compete with a cheap daily HIV-prevention pill

The Guardian
The big news from Friday. The #HIV prevention injection has been approved in #SouthAfrica https://www.spotlightnsp.co.za/2022/12/01/first-hiv-prevention-injection-approved-in-sa/ It has since been confirmed by SAHPRA. Follows roughly a year after #FDA approval. Pilot projects in SA to start early 2023, but wider rollout will depend on pricing from #ViiV. #PrEP #CABLbA #Cabotegravir